Zoetis (ZTS) Growth Weakens Amid Softening Pet Care Demand

3 weeks ago 25

Soumya Eswaran

Mon, August 3, 2026 astatine 9:20 AM CDT 3 min read

Diamond Hill Capital, a First Eagle Investment Management company, issued its Q2 2026 capitalist missive for its "Large Cap Strategy". A transcript of the missive is disposable to download here. The Strategy returned 3.42% nett of fees, trailing the Russell 1000 Value Index's 13.87% gain. Performance benefited from banal enactment successful user staples, materials and user discretionary, on with an underweight successful utilities. However, banal enactment successful accusation technology, wellness attraction and industrials detracted from comparative performance. AI remained the ascendant marketplace theme, driving an 81% summation successful technology, portion vigor declined aft the Iran warfare ended and lipid prices fell. The Strategy's constricted vulnerability to companies benefiting from AI-related superior spending caused astir of its underperformance, portion bundle holdings remained pressured by concerns astir AI disruption. Despite elevated marketplace valuations, the squad continues to find charismatic opportunities done bottom-up probe and expects progressive absorption to enactment better-than-market returns. In addition, delight cheque the Strategy's apical 5 holdings to cognize its champion picks successful 2026.

In its second-quarter 2026 capitalist letter, Diamond Hill Capital Large Cap Strategy highlighted Zoetis Inc. (NYSE:ZTS). Zoetis Inc. (NYSE:ZTS), an carnal wellness institution focused connected carnal wellness medications, vaccines, and diagnostic products, detracted from the Fund's show during the quarter. On July 31, 2026, Zoetis Inc. (NYSE:ZTS) closed astatine $77.29 per share. One-month instrumentality of Zoetis Inc. (NYSE:ZTS) was 6.98%, and its shares mislaid 47.91% implicit the past 52 weeks. Zoetis Inc. (NYSE:ZTS) has a marketplace capitalization of astir $32.40 billion.

Diamond Hill Capital Large Cap Strategy stated the pursuing regarding Zoetis Inc. (NYSE:ZTS) in its Q2 2026 capitalist letter:

"Shares of Zoetis Inc. (NYSE:ZTS), an carnal wellness company, underperformed aft the institution reported level integrated gross maturation and lowered full-year guidance amid softer US companion-animal demand, less veterinary visits and a much competitory market. These results heightened concerns that slowing maturation successful the bequest portfolio could make a near-term net spread earlier newer pipeline products lend much meaningfully."

Is Zoetis a Unique Dividend Play successful the Pharma Space for 2025?

Zoetis Inc. (NYSE:ZTS) is not on our database of the 40 Most Popular Stocks Among Hedge Funds. As per our database, 57 hedge money portfolios held Zoetis Inc. (NYSE:ZTS) at the extremity of the first quarter which was 69 in the erstwhile quarter. While we admit the imaginable of Zoetis Inc. (NYSE:ZTS) as an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

Read Entire Article